Skip to content
Back to resident companies

MicroQuin

Investment areas

  • Biotech / Life Sciences
Founders & Leadership
Scott Robinson
Alan Barge
Keith Wilcoxen
Agnes Kiu Weber
Eugene Tierney
Peter Sennhenn
Headquarters
Cambridge, MA

Revolutionizing injury/disease treatment by controlling the Intracellular Environment (ICE).

The Tough Tech problem we are solving

All disease and injury stem from IntraCellular Environmental (ICE) change, a detrimental shift in a cell's internal state that disrupts its behavior, growth, and life processes, yet no therapies directly target this root cause across broad disease categories.

About our solution

MicroQuin's small molecules modulate ICE regulators to revert cells to healthy states, slowing, stopping, or reversing disease and injury progression. This transformative approach redefines treatment paradigms for a wide spectrum of conditions by addressing the cellular origin shared by diverse pathologies.